Background Advanced age is a well-known risk factor for poor prognosis in COVID-19.
However, few studies have specifically focused on very old inpatients with COVID-19. This study …

Background Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19
compared to non-IS patients is not known. The aim of this study was to evaluate the clinical …

Objectives: A decrease in blood cell counts, especially lymphocytes and eosinophils, has
been described in patients with serious Severe Acute Respiratory Syndrome Coronavirus 2 (…

Aim Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause
of non–SSc-related death among these patients. We analyzed the increased cancer risk …

Background Spain has been one of the countries most affected by the COVID-19 pandemic.
Objective To create a registry of patients with COVID-19 hospitalized in Spain in order to …

Objectives: Left ventricular diastolic dysfunction (LVDD) remains poorly studied in Systemic
Sclerosis (SSc). To determine the prevalence and to define factors associated with LVDD …

Objective To assess the prevalence and causes of hepatobiliary involvement (HBI) in systemic
sclerosis (SSc), to investigate the clinical characteristics and prognosis of SSc patients …

… Perales-Fraile, Isabel; Ramos-Martínez, Antonio; Asensio-Vegas, Ángel; Martín-Jiménez,
Teodoro. … Perales-Fraile, Isabel; Universidad Autónoma de Madrid. Hospital Universitario …

Objective. Monotherapy is an option as first-line therapy for pulmonary arterial hypertension
(PAH). However, combination therapy is a beneficial alternative. Our objective was to …

A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been
reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at …